Effect of Gastrogastric Fistula Closure in Type 2 Diabetes

Obesity Surgery
Katherine M MeisterAli Aminian

Abstract

Roux-en-Y gastric bypass (RYGB) has been shown to significantly improve glucose control in patients with type 2 diabetes (T2DM). The formation of a gastrogastric fistula (GGF) allows nutrients to pass through the native route, rather than bypassing the duodenum in typical RYGB configuration. We sought to evaluate the effect of revisional bariatric surgery for known GGF on control of diabetes. A retrospective chart review of a single academic institution was performed to identify patients who had T2DM at the time of corrective surgery for a GGF. Baseline characteristics, and postoperative outcomes including changes in body mass index (BMI), glycated hemoglobin, fasting blood glucose (FBG), and diabetes medications were assessed. Ten patients were identified with GGF who had T2DM at the time of corrective surgery. Patients had a male-to-female ratio of 2:3, a mean age of 59.2 ± 10 years, a mean baseline BMI of 38.1 ± 17.6 kg/m2, and a median duration of 9 years (interquartile range 6-14) from initial RYGB to revision. At a mean follow-up of 14.9 ± 8.5 months, a mean reduction in BMI of 4.9 ± 6 kg/m2 was associated with a significant mean reduction in FBG (167.1 ± 88.2 vs. 106.1 ± 20.4 mg/dL, p = 0.04) and number of diabetes medic...Continue Reading

References

Apr 1, 1995·Annals of Surgery·S G CucchiE J Morgan
Jul 1, 1997·Journal of the American College of Surgeons·L D MacLeanA P McLean
Aug 24, 2006·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Lester CarrodeguasRaul Rosenthal
Apr 4, 2013·Obesity Surgery·Ciaran S O'BrienBlandine Laferrère
Apr 30, 2014·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Stacy A BrethauerJohn M Morton
May 25, 2015·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Ricard CorcellesPhilip R Schauer
Jul 16, 2015·Diabetes Technology & Therapeutics·Ali AminianStacy A Brethauer
Jun 18, 2016·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Jens Juul Holst, Sten Madsbad
Aug 29, 2016·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Rebecca L Paszkiewicz, Richard N Bergman
Aug 29, 2016·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Geltrude Mingrone, David E Cummings
Aug 29, 2016·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Steven K Malin, Sangeeta R Kashyap
Sep 28, 2016·Annals of the New York Academy of Sciences·Chelsea R Hutch, Darleen A Sandoval
Feb 9, 2017·Diabetes Care·Ali AminianPhilip R Schauer
Feb 16, 2017·The New England Journal of Medicine·Philip R SchauerUNKNOWN STAMPEDE Investigators
Jul 26, 2017·Annals of Surgery·Ali AminianPhilip R Schauer

❮ Previous
Next ❯

Citations

Oct 27, 2021·Journal of Diabetes Science and Technology·Harith RajagopalanAlan D Cherrington

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.